Listed drug firms likely to cut dividend payouts on worst profits

Korean pharmaceutical listed firms are considering slashing their cash dividends to be paid out to their shareholders this year as most of their operating profits and net incomes tumbled by more than 10 percent last year due to the government’s forced cut in drug prices last April, data showed Tuesday.

However, these listed firms plan to pay out cash dividends by 80 to 90 percent from those ...